1 LINE ITEM FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER
$109,085,460
| Recipient | TEVA PHARMACEUTICALS USA, INC. UEI NEN9A34LRHJ5 |
|---|---|
| Award ID | 36E79722D0021 |
| Award amount | $109,085,460 |
| Award type | — |
| Awarding agency | Department of Veterans Affairs — Department of Veterans Affairs |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Jul 28, 2022 |
| End date | — |
| Place of performance | — |
| Record updated | Mar 29, 2022 |
View the official award record
More awards won by TEVA PHARMACEUTICALS USA, INC.
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $25,000,000,000 · Jun 1, 2026
NEW AWARD FOR GLATIRAMER ACETATE INJECTIONS WITH TEVA PHARMACEUTICALS USA, INC. ORDERING PERIOD IS AUGUST 5, 2023 TO AUGUST 4, 2024 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $64,352,515 · Aug 5, 2023
4610093994!MANUFACTURE/DISTRIBUTOR BR-PH
Department of Defense · $5,687,207 · Aug 31, 2022
8511147946!ADENOVIRUS TYPE 4 A
Department of Defense · $5,285,022 · Jan 28, 2025
8511984334!ADENOVIRUS TYPE 4 A
Department of Defense · $3,950,554 · Mar 18, 2026
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids